… by the proliferation of terminally differentiated antibody-producing plasma cells (PCs) [1,2]. …
bortezomib-induced proteasome inhibition and ER stress, and subsequent tumor cell death …

… its potential effect on telomerase activity (TA) in MM cells. … proteasome inhibitor bortezomib
(Brt) inhibits TA in MM cells by … a differential ability of both drugs to inhibit proliferation and …

… In the analysis we combined the data of 36 cell lines for which 34 drugs gave differential …
Drug sensitivity to the proteasome inhibitor Bortezomib [53] was associated with hsa-let-7a-5p …

… the clinically approved proteasome inhibitor bortezomib. We … MDA-MD-468 breast cancer
cells, treated with either DMSO … Differentiated plasma cells are hypersecretory and thus rely …

… caused by the proteasome inhibitor bortezomib. Overall, our … target HGSOC cells of differential
platinum sensitivities via … breast cancer and castration-resistant prostate cancer [14,64]…

… the shortcomings of current proteasome inhibitors, we need … for TNBC treatment, we examined
the differential expression … To test this, we used bortezomib-resistant cell lines that were …

… mainly in myeloma and breast cancer. These studies reported that the … , bortezomib, and
ixazomib) to analyze their differential … of the proteasome inhibitors carfilzomib, bortezomib, and …

… the growth of PC cells. The proteasome inhibitor, BZ, has the same inhibitory effect on the …
Our results from cells transfected with AR DNA or PSMA DNA would also be more relevant …

… Interestingly, a shorter treatment time of 8 h, however, was accompanied by … proteasome
inhibitor, Bortezomib, caused the upregulation of the tested anti-apoptotic proteins in both cell …

… vulnerable breast cancer subtype to proteasome inhibition … sensitivity to the proteasome
inhibitors bortezomib, carfilzomib, … Differential expression between breast cancer and normal …